OptimizeRx stock has undergone multiple analysts rating changes in the recent past. OptimizeRx Upgraded by Zacks Investment Research on 10/28/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.
Shares of OptimizeRx traded up $1.51 on Wednesday, reaching $95.93. 47969 shares of the stock traded hands, compared to its average volume of 495933. Shares of OptimizeRx were trading at $95.93 on Wednesday. The firm’s 50 day moving average is $76.77 and its 200 day moving average is $58.14.OptimizeRx has a 12 month low of $94.51 and a 12 month high of $98.15. While on yearly highs and lows, OptimizeRx’s today has traded high as $97.94 and has touched $94.51 on the downward trend. See More Analyst Rating at: RATING
OptimizeRx Earnings and What to expect:
OptimizeRx last posted its earnings results on August 4th, 2021. The reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.02 by $0.08. The firm had revenue of $13.63 million for the quarter, compared to analysts’ expectations of $12.35 million. OptimizeRx has generated $0.00 earnings per share over the last year ($0.12 diluted earnings per share) and currently has a price-to-earnings ratio of 806.1. Earnings for OptimizeRx are expected to grow by 63.33% in the coming year, from $0.30 to $0.49 per share. OptimizeRx has confirmed that its next quarterly earnings report will be published on Tuesday, November 9th, 2021.
Earnings for OptimizeRx are expected to grow by 63.33% in the coming year, from $0.30 to $0.49 per share. The P/E ratio of OptimizeRx is 786.83, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 15.12. The P/E ratio of OptimizeRx is 786.83, which means that it is trading at a more expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 40.54. OptimizeRx has a P/B Ratio of 28.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
OptimizeRx (NASDAQ:OPRX) Moving Average Technical Analysis
5 day Moving Average is $94.85 And 5 day price change is -$1.62 (-1.65%) with average volume for 5 day average is 152,827. While technical analysis for average 20 days shows significant difference, 20 day moving average is $87.92 and 20 day price change is $10.83 (12.66%) and average 20 day moving volume is 490,202. 50 day moving average is $76.77 and 50 day price change is $38.22 ( 65.72%) and with average volume for 50 days is : 359,461. 200 day moving average is $58.14 and 200 day price change is $58.20 (152.44%) and with average volume for 200 days is : 251,470.
Other owners latest trading in OptimizeRx :
- On 10/27/2021 shares held by Greenwood Capital Associates LLC were 24,862 which equates to market value of $2.13M and appx 0.30% owners of OptimizeRx
- On 10/27/2021 shares held by Cannon Global Investment Management LLC were 38,207 which equates to market value of $3.27M and appx 4.90% owners of OptimizeRx
- On 10/26/2021 shares held by Taylor Wealth Management Partners were 20,368 which equates to market value of $1.74M and appx 0.60% owners of OptimizeRx
- In total Institutional ownership equates to Institutional Ownership Percentage: 67.39% for OptimizeRx
See More Analyst Rating at: RATING
